Netbasequid

FEBRUARY 22, 2021

In their paper on Deep Tech: The Great Wave of Innovation , BCG and Hello Tomorrow explain “what deep tech is, how it works, how different stakeholders can contribute to it, and how it can be harnessed for competitive advantage.” Investment intelligence to inform deep tech understanding. Patents Reveal Emerging Innovations.

Biotech 98

Biotech Innovation Intellectual Property Market Research 98

Alpha Sense BI

FEBRUARY 8, 2023

Specifically, within the pharma and biotech sectors, there have been 22 deals announced so far in 2023 — again, a low number compared to the 70 made over the same period last year. Additionally, unprofitable biopharma, aka most biotech companies, is expected to invest $1.1 In 2021, Spinraza sales reached $1.9

Biotech 96

Biotech Research Innovation Capital 96

Alpha Sense BI

APRIL 29, 2024

Market Analysis : A valuable tool for conducting market research , as it can analyze large volumes of market data, predict market trends, analyze customer preferences, and provide a snapshot of the competitive landscape. Forecasting Analysis : Analyze financial data to generate potential forecasts.

Capital 52

Capital Due Diligence Biotech Startups 52

Sedulo

MARCH 15, 2023

As leaders in competitive strategy consulting, serving the life sciences community for the last 17 years, Sedulo Group can help you: Build a comprehensive view of the current and future competitive landscape. Obtain details on competitor clinical trial locations. Assess and benchmark enrollment timing.

Biotech 52

Biotech Competitive Landscape Pharmaceutical Benchmarking 52

Alpha Sense BI

AUGUST 30, 2023

As time goes on and more firms adopt AI tools, these capabilities will become even more essential to maintain a competitive advantage. Research shows that the AI in asset management market will grow at a staggering 34% CAGR through 2027. Artificial intelligence is the only way to do it.

Management 98

Management Biotech Due Diligence Algorithm 98

Alpha Sense BI

MARCH 13, 2024

billion acquisition of Carmot Therapeutics, a clinical-stage biotechnology company with three GLP-1 assets in clinical production, including its CT-388 lead GLP-1 asset, in the hopes of gaining a competitive footing among Novo Nordisk and Eli Lilly’s products currently on the market (Ozempic, Wegovy, and Mounjaro, respectively).

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59

Alpha Sense BI

APRIL 19, 2024

2020 and 2021 were marked by increased innovation, accelerated growth, and workforce expansion. On the other hand, 2022 and 2023 brought mass layoffs , falling market capitalizations, and a weakening of global tech spending. Over the past few years, the technology industry has experienced dramatic highs and lows. OpenAI’s ChatGPT ).

Technology 69

Technology Technology Retail Biotech 69